tradingkey.logo
tradingkey.logo
Pesquisar

Zhongchao Inc

ZCMD
Adicionar à lista de desejos
1.460USD
+0.030+2.07%
Fechamento 05/15, 16:00ETCotações atrasadas em 15 min
5.63MValor de mercado
PerdaP/L TTM

Mais detalhes de Zhongchao Inc Empresa

Zhongchao Inc is a holding company engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public in China. The Company operates its businesses through two segments. MDMOOC Services segment engages in the provision of training and education services and assistance in patient-aid projects. Sales of Patented Drugs segment mainly engages in the sales of patented drugs. Under the MDMOOC brand, the Company offers a wide range of online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content to healthcare professionals as well as the public.

Informações de Zhongchao Inc

Código da empresaZCMD
Nome da EmpresaZhongchao Inc
Data de listagemFeb 19, 2020
CEOYang (Weiguang)
Número de funcionários111
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 19
Endereço841 Yan An Middle Road, Jing An District
CidadeSHANGHAI
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísChina
Código postal200040
Telefone862132205987
Sitehttps://www.mdmooc.org/
Código da empresaZCMD
Data de listagemFeb 19, 2020
CEOYang (Weiguang)

Executivos da empresa Zhongchao Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Weiguang Yang
Mr. Weiguang Yang
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
8.59K
-699.98%
Ms. Pei Xu
Ms. Pei Xu
Chief Financial Officer, Company Secretary, Director
Chief Financial Officer, Company Secretary, Director
458.00
--
Dan Li
Dan Li
Independent Director
Independent Director
241.00
-698.76%
Mr. Xuejun Chen
Mr. Xuejun Chen
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Baoqian Tian
Mr. Baoqian Tian
Chief Sales Officer
Chief Sales Officer
--
--
Ms. Shuang Wu
Ms. Shuang Wu
Chief Operating Officer
Chief Operating Officer
--
--
John General
John General
Independent Director
Independent Director
--
--
Mr. Kevin D. Vassily
Mr. Kevin D. Vassily
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Weiguang Yang
Mr. Weiguang Yang
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
8.59K
-699.98%
Ms. Pei Xu
Ms. Pei Xu
Chief Financial Officer, Company Secretary, Director
Chief Financial Officer, Company Secretary, Director
458.00
--
Dan Li
Dan Li
Independent Director
Independent Director
241.00
-698.76%
Mr. Xuejun Chen
Mr. Xuejun Chen
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Baoqian Tian
Mr. Baoqian Tian
Chief Sales Officer
Chief Sales Officer
--
--
Ms. Shuang Wu
Ms. Shuang Wu
Chief Operating Officer
Chief Operating Officer
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2024
FY2023
FY2022
Por EmpresaUSD
Nome
Receita
Proporção
Medical training and education services
7.70M
48.57%
Patiend management services in patient aid projects
5.91M
37.25%
Sales of patented drugs
2.15M
13.56%
Other revenues
97.78K
0.62%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Medical training and education services
7.70M
48.57%
Patiend management services in patient aid projects
5.91M
37.25%
Sales of patented drugs
2.15M
13.56%
Other revenues
97.78K
0.62%

Distribuição de ações

Atualizado em: qua, 13 de mai
Atualizado em: qua, 13 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Yang (Weiguang)
0.27%
Citadel Advisors LLC
0.13%
Worthy Health Limited Partnership
0.12%
Susquehanna International Group, LLP
0.08%
Two Sigma Investments, LP
0.07%
Outro
99.33%
Investidores
Investidores
Proporção
Yang (Weiguang)
0.27%
Citadel Advisors LLC
0.13%
Worthy Health Limited Partnership
0.12%
Susquehanna International Group, LLP
0.08%
Two Sigma Investments, LP
0.07%
Outro
99.33%
Tipos de investidores
Investidores
Proporção
Individual Investor
0.30%
Hedge Fund
0.20%
Corporation
0.12%
Investment Advisor
0.08%
Venture Capital
0.04%
Outro
99.25%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q4
5
46.53K
0.35%
--
2026Q1
9
10.45K
0.32%
+1.43K
2025Q4
10
19.22K
0.07%
-91.25K
2025Q3
9
76.31K
0.31%
+27.32K
2025Q2
16
6.21M
25.01%
+5.90M
2025Q1
16
6.21M
25.01%
+5.90M
2024Q4
12
290.74K
5.74%
+8.25K
2024Q3
12
266.95K
5.35%
-114.71K
2024Q2
13
300.94K
7.08%
-44.59K
2024Q1
14
279.19K
6.00%
-52.36K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Yang (Weiguang)
68.75K
2.14%
+68.75K
--
Aug 25, 2025
Citadel Advisors LLC
4.21K
0.13%
+1.89K
+81.78%
Dec 31, 2025
Worthy Health Limited Partnership
32.12K
1%
--
--
Dec 31, 2024
Susquehanna International Group, LLP
2.54K
0.08%
+2.54K
--
Dec 31, 2025
Two Sigma Investments, LP
2.32K
0.07%
+2.32K
--
Dec 31, 2025
XTX Markets LLC
1.39K
0.04%
+1.39K
--
Dec 31, 2025
Li (Dan)
1.93K
0.06%
+1.63K
+541.67%
Dec 31, 2024
General (John C)
1.93K
0.06%
+1.63K
+541.67%
Dec 31, 2024
Vassily (Kevin)
1.93K
0.06%
+1.63K
+541.67%
Dec 31, 2024
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Feb 26, 2026
Merger
8→1
Feb 27, 2024
Merger
10→1
Feb 27, 2024
Merger
10→1
Feb 27, 2024
Merger
10→1
Feb 27, 2024
Merger
10→1
Data
Data ex-dividendo
Tipo
Proporção
Feb 26, 2026
Merger
8→1
Feb 27, 2024
Merger
10→1
Feb 27, 2024
Merger
10→1
Feb 27, 2024
Merger
10→1
Feb 27, 2024
Merger
10→1
KeyAI